chartexchange

ARVN
Arvinas, Inc
stockNASDAQ

At CloseNov 13, 2026 3:59:59 PM EST
6.82USD-0.728%(-0.05)879,357
Pre-marketNov 13, 2026 8:18:30 AM EST
6.83USD-0.582%(-0.04)
After-hoursNov 13, 2026 4:00:30 PM EST
6.82USD0.000%(-0.00)
Loading…
Loading…
446.28M
Healthcare
Biotechnology
HQ
New Haven, CT, USA
Previous Close
$6.87
Beta
1.35
52-Week High
$14.51 2026-03-10
52-Week Low
$6.33 2026-11-09
SMA 50
$7.67
SMA 200
$9.43
Avg. Vol 10D
1.12M
Avg. Vol 30D
842,557
Avg. Vol 90D
808,387
Relative Vol
1.04
56.91M
0.3600%
1,300,000
400
ARVN Profile

arvinas is a pharmaceutical company focused on developing new small molecules ‒ known as protacs (proteolysis targeting chimeras) ‒ aimed at degrading disease-causing cellular proteins via proteolysis. based on innovative research conducted at yale university by dr. craig crews, founder and chief scientific advisor, the company is translating natural protein degradation approaches into novel drugs for the treatment of cancer and other diseases. the proprietary protac-based drug paradigm induces protein degradation, rather than protein inhibition, using the ubiquitin proteasome system and offers the advantage of potentially targeting "undruggable" as well as "druggable" elements of the proteome. this greatly expands the ability to create drugs for many new, previously unapproachable targets. for more information, visit www.arvinas.com.

ARVN Performance
PeriodPriceDateChangeBeta
1W6.412026-11-06+6.32%1.259
1M6.842026-10-13-0.36%2.073
3M9.012026-08-13-24.36%1.756
6M9.872026-05-13-30.95%1.453
1Y10.122025-11-13-32.66%1.351
2Y25.342024-11-13-73.11%—
5Y84.372021-11-12-91.92%1.382
ARVN Stock Summary

Arvinas, Inc (NASDAQ:ARVN) stock price today is $6.82, and today's volume is 879,357. ARVN is down 0.801% today. The 30 day average volume is 842,557. ARVN market cap is $446.28M with 65.49M shares outstanding.